Sachem Capital (SACH) Gets a Hold from JMP Securities
In a report released today, Chris Muller from JMP Securities reiterated a Hold rating on Sachem Capital (SACH – Research Report). The ...
Sutro Biopharma, Inc.: Sutro Biopharma Reports Third Quarter 2024 Financial Results and Business Highlights
Expects to deliver three Investigational New Drug (IND) applications in next three years based on next-generation ADC technology - - Two new clinical trials, REFRaME-P1, a registration-enabling trial ...